Cargando…

Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer

PURPOSE: Prostate cancer (PCa) has a highly heterogeneous outcome. Beyond Gleason Score, Prostate Serum Antigen and tumor stage, nowadays there are no biological prognostic factors to discriminate between indolent and aggressive tumors. The most common known genomic alterations are the TMPRSS-ETS tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo Iacono, Marco, Buttigliero, Consuelo, Monica, Valentina, Bollito, Enrico, Garrou, Diletta, Cappia, Susanna, Rapa, Ida, Vignani, Francesca, Bertaglia, Valentina, Fiori, Cristian, Papotti, Mauro, Volante, Marco, Scagliotti, Giorgio V., Porpiglia, Francesco, Tucci, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924723/ https://www.ncbi.nlm.nih.gov/pubmed/26887047 http://dx.doi.org/10.18632/oncotarget.7343

Ejemplares similares

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
por: Tucci, Marcello, et al.
Publicado: (2018)

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
por: Iuliani, Michele, et al.
Publicado: (2015)

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives
por: Zichi, Clizia, et al.
Publicado: (2017)

Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing
por: Righi, Luisella, et al.
Publicado: (2013)

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review
por: Marandino, Laura, et al.
Publicado: (2020)

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle
por: Berruti, Alfredo, et al.
Publicado: (2010)

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways
por: Bungaro, Maristella, et al.
Publicado: (2020)

mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein
por: Guglielmelli, Tommasina, et al.
Publicado: (2015)

Differential Expression Profiles of Cell-to-Matrix-Related Molecules in Adrenal Cortical Tumors: Diagnostic and Prognostic Implications
por: Volante, Marco, et al.
Publicado: (2021)

Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation
por: Lo Iacono, Marco, et al.
Publicado: (2011)

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids
por: Rapa, Ida, et al.
Publicado: (2018)

Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors
por: Metovic, Jasna, et al.
Publicado: (2022)

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis
por: Fiorica, Francesco, et al.
Publicado: (2022)

Adrenal Rests in the Uro-genital Tract of an Adult Population
por: Falco, Enrico Costantino, et al.
Publicado: (2021)

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
por: Ungaro, Antonio, et al.
Publicado: (2022)

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
por: Audisio, Alessandro, et al.
Publicado: (2022)

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
por: Passiglia, Francesco, et al.
Publicado: (2022)

Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines
por: Monica, Valentina, et al.
Publicado: (2016)

Renal cancer: From current evidence to future perspectives
por: Fiori, Cristian, et al.
Publicado: (2022)

Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma
por: Napoli, Francesca, et al.
Publicado: (2021)

Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
por: Volante, Marco, et al.
Publicado: (2021)

A Fully Automatic Artificial Intelligence System Able to Detect and Characterize Prostate Cancer Using Multiparametric MRI: Multicenter and Multi-Scanner Validation
por: Giannini, Valentina, et al.
Publicado: (2021)

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
por: Ortolan, Erika, et al.
Publicado: (2014)

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
por: Turco, Fabio, et al.
Publicado: (2023)

CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells
por: Germano, Antonina, et al.
Publicado: (2018)

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
por: Audisio, Marco, et al.
Publicado: (2022)

Molecular Characterization of Prostate Cancers in the Precision Medicine Era
por: Giunta, Emilio Francesco, et al.
Publicado: (2021)

Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature
por: Brizzi, Maria Pia, et al.
Publicado: (2015)

Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center
por: Bungaro, Maristella, et al.
Publicado: (2021)

Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now?
por: Mecca, Caterina, et al.
Publicado: (2019)

Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer
por: Silvia, Saviozzi, et al.
Publicado: (2006)

Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation
por: Doghman, Mabrouka, et al.
Publicado: (2013)

Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical Needs
por: Turco, Fabio, et al.
Publicado: (2022)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
por: Porpiglia, Francesco, et al.
Publicado: (2015)

Three-dimensional automatic artificial intelligence driven augmented-reality selective biopsy during nerve-sparing robot-assisted radical prostatectomy: A feasibility and accuracy study
por: Checcucci, Enrico, et al.
Publicado: (2023)

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report
por: Zichi, Clizia, et al.
Publicado: (2018)

Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
por: Siddiqui, Mohammad Aarif, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6lefjppfpkga0fea03kakoch7g